Sodium fluoride: an ineffective inhibitor of glycolysis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Entrenched in current laboratory protocols for the measurement of plasma glucose is the false belief that sodium fluoride (NaF) is an effective inhibitor of glycolysis. The failure of NaF to properly control glycolysis decreases plasma glucose concentrations. The amount of the decrease can be clinically significant. The most recent (2011) laboratory guidelines for diagnosis and management of diabetes mellitus, approved by the American Diabetes Association, no longer recommend the use of NaF alone to control glycolysis. If plasma cannot be iced and separated from cells within 30 min of collection, the new guidelines recommend the use of a tube that contains a low pH buffer such as citrate. Proper control of glycolysis will affect current glucose cut-off points, but the exact effect is yet to be defined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normal fasting plasma glucose levels and type 2 diabetes in young men
Tirosh, A., Shai, I., Tekes-Manova, D., Israeli, E., Pereg, D., Shochat, T., Kochba, I., & Rudich, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050080 · Cited by 508
Effectiveness of sodium fluoride as a preservative of glucose in blood
Chan, A. Y., Swaminathan, R., & Cockram, C. S. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.2.315 · Cited by 289
Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis
Gambino, R., Piscitelli, J., Ackattupathil, T. A., Theriault, J. L., Andrin, R. D., Sanfilippo, M. L., & Etienne, M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.121707 · Cited by 160
Self-citationStabilization of glucose in blood samples: why it matters
Bruns, D. E., & Knowler, W. C. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.126037 · Cited by 125
A new method of inhibiting glycolysis in blood samples
Uchida, K., Matuse, R., Toyoda, E., Okuda, S., & Tomita, S. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90125-8 · Cited by 53
Cited by
Interferences from blood collection tube components on clinical chemistry assays
Bowen, R. A. R., & Remaley, A. T. (2014) · Biochemia Medica · doi:10.11613/bm.2014.006 · Cited by 316
Thompson-Branch, A., & Havranek, T. (2017) · Pediatrics In Review · doi:10.1542/pir.2016-0063 · Cited by 176
Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results
Pasqualetti, S., Braga, F., & Panteghini, M. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.03.009 · Cited by 41
“sole exception of Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study-derived limit for GDM diagnosis] were derived from studies using sodium fluoride tubes and, thus, the decision limits are probably based on data that were generated with approaches in collecting blood for PG measurements that were negatively bi…”
MethodBlood Glucose Determination: Effect of Tube Additives
(2018) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2017.12.003 · Cited by 28
Jamieson, E. L., Spry, E. P., Kirke, A. B., Atkinson, D. N., & Marley, J. V. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16224488 · Cited by 27
“Whilst plasma glucose instability has been raised as an important consideration by some groups [18,25], the extent to which glycolysis impacts GDM diagnosis for women in diverse rural and remote Australian settings has not been previously characterised.”
BackgroundDibbasey, M., Umukoro, S., & Bojang, A. (2024) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2024.e00360 · Cited by 5
Metadata
- Authors
- Gambino, R.
- Venue
- Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Publisher
- SAGE Publications
- Published
- 2012-11-05
- Volume
- 50
- Issue
- 1
- Pages
- 3-5
- ISSN
- 0004-5632 (ISSN-L)
- 1758-1001
- OpenAlex
- W2084808422
- Cited by
- 50
- References
- 5
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.